How is CRPS treated, and what does the evidence say?
Complex regional pain syndrome (CRPS) is treated with physical and occupational therapy, pain relief, education and psychological care together, with nerve blocks or implanted stimulators for some people. A 2023 Cochrane overview of 17 systematic reviews found no high-certainty evidence for any CRPS treatment. Guidelines still recommend starting rehabilitation early.

- 0CRPS treatment comparisons were supported by high-certainty evidence in a 2023 Cochrane overview of 17 systematic reviewsFerraro et al., Cochrane Database of Systematic Reviews, 2023
- 34randomized trials of physiotherapy for CRPS, with 1,339 participants, were all graded very low certaintySmart et al., Cochrane Database of Systematic Reviews, 2022
- $43,026median cumulative health care cost in the eight years after a CRPS diagnosis among 35,316 insured United States patientsElsamadicy et al., Neuromodulation, 2018
What is the main treatment for CRPS?
The main treatment for complex regional pain syndrome is rehabilitation that restores use of the limb, supported by pain relief, education and psychological care. The Royal College of Physicians' 2018 guideline names four pillars of care, "education, pain relief, physical rehabilitation and psychological intervention," and says they "have equal importance." The 2022 practical guidelines in Pain Medicine place functional restoration by an interdisciplinary team at the core of CRPS treatment.
Medication, nerve blocks and implanted devices play a supporting role in both guidelines. A 2015 review in The BMJ by Bruehl described their purpose as "to facilitate engagement in functional therapies." The Royal College of Physicians states that there is no proven cure for CRPS.
How strong is the evidence for CRPS treatments?
The evidence for most CRPS treatments is weak. A 2023 Cochrane overview by Ferraro and colleagues examined five Cochrane reviews and twelve other systematic reviews and "found no high-certainty evidence for any comparison." For a wide range of commonly used treatments, the overview reported that "the certainty in the evidence was very low and provides insufficient evidence to either support or refute their use."
Weak evidence does not show that a CRPS treatment fails. The Cochrane overview found that the trials "were typically small and mostly at high risk of bias." The tables on this page name one main study or review for each treatment and state how strong the evidence is. A certainty rating describes how much confidence reviewers place in a result.
What does the evidence say about therapy and psychological care for CRPS?
Rehabilitation therapies for CRPS are recommended first by every guideline and rest on small trials.
| Treatment | What the main study or guideline found | Evidence strength |
|---|---|---|
| Physical and occupational therapy | Cochrane review, 2022 (Smart): 34 trials left the effect on CRPS pain and disability "very uncertain" | Very low certainty; first-line in guidelines |
| Graded motor imagery | Moseley, 2006: in 51 patients with CRPS type I or phantom limb pain, pain fell 23.4 mm against 10.5 mm with usual care | Low to very low; one research team |
| Mirror therapy | McCabe, 2003: pain relief in CRPS of 8 weeks or less and no change in chronic CRPS, in 8 patients | Very low; pilot study |
| Desensitization | Recommended by the 2018 and 2022 guidelines; no randomized trial identified | Clinical opinion (level 4) |
| Exposure therapy | den Hollander, 2016: exposure reduced disability more than usual care at 6 months in 46 CRPS patients | Very low certainty (Cochrane, 2022) |
| Psychological care for CRPS | One of four pillars in the 2018 guideline; trials come mostly from other chronic pain | Low for CRPS specifically |
What does the evidence say about pills and creams for CRPS?
Most oral and topical medications used for CRPS have one small CRPS trial or none.
| Medication | What the main study or guideline found | Evidence strength |
|---|---|---|
| Corticosteroids | Christensen, 1982: all 13 patients on prednisone improved more than 75 percent, against 2 of 10 on placebo | Low; small trial in early disease |
| Gabapentin | van de Vusse, 2004: a crossover trial in CRPS type I reported "a mild effect on pain" | Low |
| Tricyclic antidepressants and SNRIs for CRPS | The 2023 Cochrane overview found no randomized trial of tricyclic antidepressants in CRPS | Borrowed from other nerve pain |
| Opioids for CRPS | One trial of controlled-release morphine found no difference from placebo after 8 days (2022 guidelines) | No supporting trial |
| Topical DMSO 50 percent cream | Zuurmond, 1996: greater improvement than placebo cream over 2 months in 32 patients with acute CRPS | Low |
| Low-dose naltrexone for CRPS | Chopra, 2013: a report of two patients | Very low; case reports |
What does the evidence say about infusions for CRPS?
Three infusion treatments for CRPS have been tested against placebo. Two showed short-term pain relief and one showed none.
| Infusion | What the main study found | Evidence strength |
|---|---|---|
| Bisphosphonates | Ferraro, 2026: across 11 trials and 754 participants, CRPS pain was 10.0 points lower on a 0 to 100 scale between 4 weeks and 3 months | Low certainty; short-term |
| Ketamine | van den Brink, 2026: across 21 studies and 605 patients, CRPS pain fell 3.6 points on a 0 to 10 scale within 14 days, then returned toward baseline by 90 days | Low to moderate; short-term |
| Low-dose immunoglobulin (IVIG) | Goebel, 2017: no benefit over placebo in 108 patients with CRPS of 1 to 5 years | Moderate, against benefit |
What does the evidence say about nerve blocks, stimulators and surgery for CRPS?
| Procedure | What the main study or review found | Evidence strength |
|---|---|---|
| Sympathetic nerve block | Cochrane overview, 2023: lidocaine sympathetic blockade "probably does not reduce pain intensity compared with placebo" | Moderate, against benefit |
| Spinal cord stimulation | Kemler, 2000: in a 54-patient trial, CRPS pain fell 2.4 cm at 6 months with stimulation; by 5 years results were similar to physical therapy alone | One randomized trial |
| Dorsal root ganglion stimulation | Deer, 2017: 81.2 percent had at least 50 percent relief of leg CRPS pain at 3 months, against 55.7 percent with spinal cord stimulation | One trial; lower limb only |
| Intrathecal baclofen pump | van Rijn, 2009: CRPS dystonia and pain improved at 12 months in 36 patients, with 89 adverse events | Low |
| Sympathectomy | Cochrane review, 2013 (Straube): one eligible study, of 20 participants, and no comparison with a sham procedure | Very low |
| Amputation | Bodde, 2011: in a review of 26 case series, CRPS recurred in the stump in 31 of 65 cases | Case series only |
Are CRPS medications approved by the FDA for CRPS?
The medications used for CRPS are prescribed off label. The National Institute of Neurological Disorders and Stroke states that the medicines "are used 'off label' to treat CRPS. This means they are approved for other conditions." The 2022 practical guidelines name Food and Drug Administration approvals only for other conditions, such as carbamazepine for trigeminal neuralgia. A 2022 article published by the American Society of Regional Anesthesia and Pain Medicine describes off-label use of ketamine as "common and supported by evidence-based medicine." The medications guide covers each drug class.
Does starting CRPS treatment early matter?
Guidelines call for early treatment of CRPS. The Royal College of Physicians' 2018 guideline says physiotherapy or occupational therapy "should be initiated immediately when CRPS is suspected." The National Institute of Neurological Disorders and Stroke says treatment is usually most effective when it is started early. The 2022 practical guidelines add that most people with early CRPS improve and that approximately 15 percent fail to recover.
Can CRPS be prevented after a fracture?
Vitamin C after a wrist fracture has been tested for preventing CRPS, with conflicting results. Zollinger's 2007 trial of 416 patients found CRPS in 2.4 percent with vitamin C and 10.1 percent with placebo. Ekrol's 2014 trial of 336 patients found no benefit. The 2022 practical guidelines call the value of vitamin C "unproven." The full account is in preventing CRPS after a fracture.
How does CRPS treatment evidence matter in a California injury claim?
A California injury claim can include the cost of future CRPS treatment. The Judicial Council's jury instruction CACI No. 3903A requires the injured person to prove "the reasonable cost of reasonably necessary medical care" that the person "is reasonably certain to need in the future." Treating doctors and a life care plan supply that proof, and insurers commonly challenge treatments that rest on weak trials.
Guides in this section
Rehabilitation and psychological care
The first-line treatments in every guideline.
- Physical and occupational therapyWhat physical and occupational therapists do for CRPS, each technique with its evidence level, how hard therapy should push, and what the trials found.
- Mirror therapy and graded motor imageryThe three steps of graded motor imagery, how a mirror session runs, the McCabe and Moseley studies with their sample sizes, and the limits of the evidence.
- Pain psychologyWhy psychological care is one of the four pillars of CRPS treatment, the methods used, the exposure trial results, and what a referral does and does not mean.
Medications and infusions
What each drug class showed in CRPS trials, and its approval status.
- Medications for CRPSEach class of medication used for CRPS, the trial behind it, its evidence strength and its approval status, with the drugs that failed in trials.
- Ketamine infusionsThe two randomized trials and the meta-analyses of ketamine infusions for CRPS, how long relief lasts, side effects, approval status, cost and coverage.
- Bisphosphonates and neridronateThe bisphosphonate trials in CRPS, the 2026 meta-analysis, the stopped United States neridronate trials, guideline positions, and the Phase 3 trial with California sites.
Procedures, devices and surgery
Nerve blocks, stimulators and amputation, with outcomes and complication rates.
- Sympathetic nerve blocksStellate ganglion and lumbar sympathetic blocks: how they are done, the Cochrane findings, the Price 1998 saline result, and current guideline positions.
- Spinal cord stimulationThe Kemler randomized trial at six months and five years, long-term cohorts, revision and removal rates, costs, guideline positions, and FDA report data.
- Dorsal root ganglion stimulationHow DRG stimulation works, the 2016 FDA approval and its lower-limb limit, ACCURATE trial results and weaknesses, and the post-approval study.
- Amputation for CRPSWhat the guidelines say about amputation for CRPS, and what the case series report on pain, recurrence, phantom limb pain, prosthesis use and work.
Getting care
Doctors, costs and appointments in California.
- Finding a CRPS doctor in CaliforniaWhich kinds of specialists diagnose and treat CRPS, what to ask a clinic before booking, and the California university and hospital pain programs whose own pages name CRPS.
- What CRPS treatment costsThe cost figures for CRPS care that could be verified, each with its study and year: claims studies, Medicare amounts in California, stimulator economics, ketamine prices and household costs.
- Questions to ask at a CRPS appointmentA printable list of questions for each kind of CRPS visit, grouped by visit type, with the guideline or study finding that makes each group worth asking.
- CRPS in the emergency room, at the dentist and before surgeryWhat the UK guideline, the 2022 practical guidelines and the U.S. patient organisation say about emergency visits, needles, blood pressure cuffs, dental work and surgery for a person with CRPS.
Common questions
Sources
Every source below was opened and read for this page. The date is when it was last checked.
- Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th EditionClinical guideline · Pain Medicine (Harden et al.), 2022 · checked
- Complex regional pain syndrome in adults: UK guidelines for diagnosis, referral and management in primary and secondary care, 2nd editionClinical guideline · Royal College of Physicians, 2018 · checked
- Complex Regional Pain SyndromeGovernment agency · National Institute of Neurological Disorders and Stroke · checked
- Interventions for treating pain and disability in adults with complex regional pain syndrome: an overview of systematic reviewsStudy · Cochrane Database of Systematic Reviews (Ferraro et al.), 2023 · checked
- Complex regional pain syndromeStudy · The BMJ (Bruehl), 2015 · checked
- Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and IIStudy · Cochrane Database of Systematic Reviews (Smart et al.), 2022 · checked
- Graded motor imagery for pathologic pain: a randomized controlled trialStudy · Neurology (Moseley), 2006 · checked
- A controlled pilot study of the utility of mirror visual feedback in the treatment of complex regional pain syndrome (type 1)Study · Rheumatology (McCabe et al.), 2003 · checked
- Expose or protect? A randomized controlled trial of exposure in vivo vs pain-contingent treatment as usual in patients with complex regional pain syndrome type 1Study · Pain (den Hollander et al.), 2016 · checked
- Efficacy and Safety of Bisphosphonates for Complex Regional Pain Syndrome: A Systematic Review and Meta-analysisStudy · Annals of Internal Medicine (Ferraro et al.), 2026 · checked
- The reflex dystrophy syndrome response to treatment with systemic corticosteroidsStudy · Acta Chirurgica Scandinavica (Christensen et al.), 1982 · checked
- Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1Study · BMC Neurology (van de Vusse et al.), 2004 · checked
- Treatment of acute reflex sympathetic dystrophy with DMSO 50% in a fatty creamStudy · Acta Anaesthesiologica Scandinavica (Zuurmond et al.), 1996 · checked
- Treatment of Complex Regional Pain Syndrome (CRPS) using low dose naltrexone (LDN)Study · Journal of Neuroimmune Pharmacology (Chopra and Cooper), 2013 · checked
- Intravenous ketamine for complex regional pain syndrome: Pain outcomes and predictors of response. A systematic review and meta-analysisStudy · The Journal of Pain (van den Brink et al.), 2026 · checked
- Low-Dose Intravenous Immunoglobulin Treatment for Long-Standing Complex Regional Pain Syndrome: A Randomized TrialStudy · Annals of Internal Medicine (Goebel et al.), 2017 · checked
- Spinal cord stimulation in patients with chronic reflex sympathetic dystrophyStudy · The New England Journal of Medicine (Kemler et al.), 2000 · checked
- Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trialStudy · Journal of Neurosurgery (Kemler et al.), 2008 · checked
- Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trialStudy · Pain (Deer et al.), 2017 · checked
- Intrathecal baclofen for dystonia of complex regional pain syndromeStudy · Pain (van Rijn et al.), 2009 · checked
- Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndromeStudy · Cochrane Database of Systematic Reviews (Straube et al.), 2013 · checked
- Therapy-resistant complex regional pain syndrome type I: to amputate or not?Study · The Journal of Bone and Joint Surgery, American Volume (Bodde et al.), 2011 · checked
- Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures? A randomized, controlled, multicenter dose-response studyStudy · The Journal of Bone and Joint Surgery, American Volume (Zollinger et al.), 2007 · checked
- The influence of vitamin C on the outcome of distal radial fractures: a double-blind, randomized controlled trialStudy · The Journal of Bone and Joint Surgery, American Volume (Ekrol et al.), 2014 · checked
- Prevalence and Cost Analysis of Complex Regional Pain Syndrome (CRPS): A Role for NeuromodulationStudy · Neuromodulation (Elsamadicy et al.), 2018 · checked
- Judicial Council of California Civil Jury Instructions (CACI), 2026 editionJury instruction · Judicial Council of California, 2026 · checked
- ClinicalTrials.gov study registry and APIDataset · U.S. National Library of Medicine · checked
- Ketamine Infusion Therapy and Its Role in Chronic PainOrganization · ASRA Pain Medicine News (Goordeen et al.), 2022 · checked
- Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1Study · Pain (Sigtermans et al.), 2009 · checked
